Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.
Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.
Romanian healthcare provider Santa Maria, part of listed group Medlife, has grown its revenue by fivefold since 2016 mostly from patients outsourced to it by the Romanian NHS. HBI speaks to the group's CEO to find out more.
Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.
The owner of North Macedonia's second-largest private hospital, the Zan Mitrev Clinic, tells HBI he is in discussions with outside investors and a deal could happen 'in the future'.
Population health is at the centre of a new NHS England reform that will give purchasing power to local, integrated health bodies across the UK. At first glance, the white paper points to less work for the private sector, but a new procurement system could tip it towards the system seen in Europe, where the local body often acts as a payor and the patient has a much wider choice of provider.
CEE private equity firm Penta Investments is seeking a new investor for its hospital division, Penta Hospitals International (PHI), and aims to launch a process with investment memorandums (IMs) out by the end of February, investment director Václav Jirků tells HBI. He discusses the reason for the sale, including international expansion, and the current political turmoil surrounding Penta and its healthcare business.
Credit rating agency Moody's understands that France's largest for-profit acute hospital group Elsan will "refrain from sizeable debt-funded acquisitions such as Groupe C2S over the next 12 to 18 months and focus on bolt-on acquisitions," after downgrading its debt rating outlook to 'negative' following an increase in leverage from its the deal. We talk to Elsan and L.E.K. France.
Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient.
Singaporean sovereign wealth fund GIC is leading a consortium buying into Vinmec, a not-for-profit hospital operator in Vietnam. This is the state investor's first investment into healthcare.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.